Renal Angina Lakhmir S. Chawla, MD Associate Professor of Medicine Renal Angina • • • • What the &#$@ are you talking about? Do I need to know this? Implementation Outcomes Angina – Troponin – ACS/MI Angina ACS/MI Diagnostics • EKG • Troponin Land of AKI Biomarkers Troponin Worship 50% 40.6% Am J Cardiol, 2008; 102:509 - 512 Conclusion • Troponin performance significantly deteriorates when used outside of the clinical syndrome of angina • AKI Biomarkers will only perform well when used in the appropriate context Renal Angina? Acute Flank Pain “Simply put, AKI does not hurt” Cardiac Angina Risk Factors Clinical Syndrome • • • • • • • • • DM HTN Elevated Cholesterol Family History Tobacco Use Elephant on my chest Squeezing/pressure Jaw pain Dyspnea If RF + Diagnostics > Threshold HIGH Likelihood of ACS Renal Angina Risk Factors Renal Angina Risk Factors • Mechanical Ventilation • Vasopressors • Nephrotoxins • Sepsis • MSOF • SCT • Volume Depletion Clinical Syndrome • Early evidence of AKI If RF + Diagnostics > Threshold HIGH Likelihood of ACS Pediatric Renal Angina: Risk Factors • Moderate Risk (4.5% AKI rate) – ICU admission • High Risk (11%-21% AKI rate) – Stem cell transplantation • Very High Risk (51% AKI rate) – Invasive mechanical ventilation – One vasoactive medication Pediatric Clinical Signs: Gradation Chest Pain Equivalent • Creatinine increase • Estimated creatinine clearance decrease (pRIFLE) • Fluid Accumulation from ICU admission MV 1+ pressor Decomp HF SCT Ped ICU 2+Nephrotoxin Putting Renal Angina to the Test • Preliminary data from CCHMC • Retrospective chart review of 150 patients admitted to the PICU – Median ICU LOS is 3 days • Assigned each patient risk category • Assessed for clinical signs (creatinine or fluid accumulation based) • Outcome: Day 0, 1 prediction of AKI at 72 hours • Secondary: PICU LOS, Mortality Basu, Wheeler, Chawla, Goldstein Calculating Renal Angina Index Risk Level Description Risk Score Moderate High Very High ICU status History of Transplantation Mechanical ventilation + Inotropy 1 3 5 = Renal Angina Index Score Angina > 8 Injury (Creatinine) No ↓eCrCl / No ↑[SCr] 0<x<25% ↓eCrCl / 0-33% ↑[SCr] 25%-50% ↓eCrCl / 33-100% ↑[SCr] >50% ↓eCrCl / >100% ↑[SCr] Injury (Fluid Overload) < 5% >5 % Injury Score 1 2 >10 % 4 >15 % 8 RA on Day 0 to Predict AKI on Day 3 Multivariate analysis for Renal Angina, patient age, inotropy score and PRISM II score OR for Renal Angina on Day 1 to predict AKI on Day 3 =7.1 (1.9-27, p=0.004) Basu, Wheeler, Chawla, Goldstein: ASN 2011 C statistic = 0.75-0.82 C statistic = 0.68-0.77 Summary/Conclusions • AKI biomarkers hold promise for earlier diagnosis of AKI development and intensity • Risk stratification based on demographics alone may not sufficiently enrich the population to optimize AKI biomarker utility • Renal Angina, a concept that combines risk stratification and clinical signs may serve well to optimize biomarker utility Take Home Points • Context • Comparative performance Stu Goldstein